Delivery Order SPE2DB20D3104-SPE2DB23FV8A1
- Not listed
- This federal contract award, valued at $3,192.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567806976 LIDOCAINE 5% PATCH 30S, a medical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
- This federal contract award, valued at $9,693.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,679.67 firm fixed price delivery order is for the supply of LIDOCAINE 5% PATCH 30S medical products. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $2,299.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of 4558244987 – LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has a firm fixed price and ultimate completion date of August 29, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $1,822.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4558614406 - LIDOCAINE 5% PATCH 30S, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 28, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $9,856.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, and has an ultimate completion date of July 29, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
- This federal contract award, valued at $1,623.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4568207941 LIDOCAINE 5% PATCH 30S, a medical product, with a performance period extending through May 12, 2025. The contract is designated as a Firm Fixed Price Delivery Order, with no set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $12,938.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565110719 ! LIDOCAINE 5% PATCH 30S, a pharmaceutical product, and has an ultimate completion date of July 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating...
- This federal contract award, valued at $6,283.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567057664 - LIDOCAINE 5% PATCH 30S, a medical product. The contract has a completion date of January 28, 2025 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a larger $999,999,999...
- This federal contract award, valued at $1,482.30, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of a medical product, specifically 4566774952 - LIDOCAINE 5% PATCH 30S, with a performance period ending on December 23, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV8A1Delivery Order
This federal contract award, valued at $15,850.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4561598216 - LIDOCAINE 5% PATCH 30S, a medical product. The award has an ultimate completion date of July 26, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contract vehicles enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 7/25/23 |